ACDC vs BMRN · rev $1.94B vs P/E 40, rev $1.76B
ProFrac Holding Corp. (ACDC) versus Biomarin Pharmaceutical Inc (BMRN) — a side-by-side from cached financials, not a winner call.
ProFrac Holding Corp. (ACDC) is a oil & gas equipment & services company listed on US.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Latest reported ACDC revenue for 2025-12-31 was $1.94B. Net income was -$369.0M. Revenue was down 11.4% from 2024-12-31 to 2025-12-31. ACDC currently screens at market cap $1.19B.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
ACDC currently screens at market cap $1.19B. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Not investment advice. Open the ACDC and BMRN stock pages for the full models.
Not investment advice.